Normal view MARC view ISBD view

Rationale for recombinant human interferon-gamma adjuvant immunotherapy for cancer.

Jaffe, H S

Rationale for recombinant human interferon-gamma adjuvant immunotherapy for cancer. [electronic resource] - Journal of the National Cancer Institute Jul 1988 - 616-8 p. digital

Publication Type: Journal Article; Review

ISSN: 0027-8874

Standard No.: 10.1093/jnci/80.9.616 doi

Subjects--Topical Terms:
Adjuvants, Immunologic
Animals
Combined Modality Therapy
Cytotoxicity, Immunologic
Humans
Immunotherapy--methods
Interferon-gamma--therapeutic use
Neoplasms--therapy
Recombinant Proteins--therapeutic use

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)